Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

pDNA/cationic lipid molecule nanoparticles

Based on

1 Patents
2013 Most recent source

Composition

1

bis(3,7,11,15-tetramethylhexadecyl) 1-(4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl)phenyl)-1,4-dioxo-2,5,9,14,18-pentaazahenicosan-21-ylphosphonate

Type Single Compound
Formula C72H134N11O6P
Role raw materials
2

pBsr2 pCpGLacZh plasmid

Type Biomolecule
Formula
Role raw materials

Properties

Applications

Area Application Source
medicine/veterinary

0 more entry available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Source
C57BL/6 mouse injected with B16-F1 cells

0 more entry available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • bis(3,7,11,15-tetramethylhexadecyl) 1-(4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl)phenyl)-1,4-dioxo-2,5,9,14,18-pentaazahenicosan-21-ylphosphonate
  • pBsr2 pCpGLacZh plasmid
Product

pDNA/cationic lipid molecule nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial